Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$4.75B |
| 2 |
Walmart Inc
WMT
|
+$3.98B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.42B |
| 4 |
Broadcom
AVGO
|
+$943M |
| 5 |
iShares Bitcoin Trust
IBIT
|
+$785M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$572M |
| 2 |
NVIDIA
NVDA
|
+$566M |
| 3 |
Apple
AAPL
|
+$554M |
| 4 |
AbbVie
ABBV
|
+$455M |
| 5 |
Bank of America
BAC
|
+$411M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.52% |
| 2 | Healthcare | 7.46% |
| 3 | Financials | 6.74% |
| 4 | Industrials | 6.14% |
| 5 | Consumer Discretionary | 4.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3901
Provident Financial Services
PFS
$3.22B
| $1.85M | ﹤0.01% |
93,904
-4,930
| -5% | -$95.3K |
|
3902
CenterPoint Energy
CNP
$27.7B
| $1.85M | ﹤0.01% |
48,347
-5,800,404
| -99% | -$226M |
|
3903
CALL
Symbotic
SYM
$5.48B
| $1.85M | ﹤0.01% |
31,100
-18,100
| -37% | -$1.2M |
|
3904
Integra LifeSciences
IART
$1.29B
| $1.85M | ﹤0.01% |
148,971
-75,995
| -34% | -$1.01M |
|
3905
PUT
Fidelity National Information Services
FIS
$23.1B
| $1.85M | ﹤0.01% |
27,800
-7,900
| -22% | -$521K |
|
3906
Ameris Bancorp
ABCB
$5.85B
| $1.84M | ﹤0.01% |
24,838
-645,474
| -96% | -$48M |
|
3907
Marcus & Millichap
MMI
$1.16B
| $1.84M | ﹤0.01% |
67,388
-104,879
| -61% | -$3.03M |
|
3908
CALL
Blue Owl Capital
OWL
$6.96B
| $1.84M | ﹤0.01% |
122,900
+41,600
| +51% | +$650K |
|
3909
Coursera
COUR
$1.52B
| $1.84M | ﹤0.01% |
249,429
-422,983
| -63% | -$3.68M |
|
|
ALDF
3910
Aldel Financial II Inc
ALDF
$320M
| $1.84M | ﹤0.01% |
175,000
| – | – |
|
3911
Centuri Holdings
CTRI
$2.81B
| $1.83M | ﹤0.01% |
72,651
-1,192,486
| -94% | -$26.7M |
|
|
WRN
3912
Western Copper and Gold
WRN
$460M
| $1.83M | ﹤0.01% |
686,447
+433,420
| +171% | +$1M |
|
3913
Alvotech
ALVO
$1.39B
| $1.83M | ﹤0.01% |
357,176
+337,417
| +1,708% | +$2.13M |
|
|
MRSN
3914
DELISTED
Mersana Therapeutics
MRSN
| $1.83M | ﹤0.01% |
63,305
-14,684
| -19% | -$279K |
|
3915
CALL
Teleflex
TFX
$6.05B
| $1.83M | ﹤0.01% |
+15,000
| New | +$1.82M |
|
3916
Custom Truck One Source
CTOS
$2.31B
| $1.83M | ﹤0.01% |
+317,801
| New | +$1.94M |
|
3917
Immunic
IMUX
$190M
| $1.82M | ﹤0.01% |
341,930
+288,883
| +545% | +$2.12M |
|
3918
PUT
ADMA Biologics
ADMA
$1.96B
| $1.82M | ﹤0.01% |
+100,000
| New | +$1.69M |
|
|
NHIC
3919
NewHold Investment Corp III
NHIC
$296M
| $1.81M | ﹤0.01% |
175,000
| – | – |
|
3920
Frontline
FRO
$8.76B
| $1.81M | ﹤0.01% |
83,092
-430,050
| -84% | -$10.1M |
|
|
AVDL
3921
DELISTED
Avadel Pharmaceuticals
AVDL
| $1.81M | ﹤0.01% |
84,085
-8,315
| -9% | -$161K |
|
3922
CALL
Darling Ingredients
DAR
$9.64B
| $1.81M | ﹤0.01% |
50,300
-12,500
| -20% | -$423K |
|
3923
Abeona Therapeutics
ABEO
$366M
| $1.81M | ﹤0.01% |
343,568
-365,781
| -52% | -$1.84M |
|
|
PKST
3924
DELISTED
Peakstone Realty Trust
PKST
| $1.81M | ﹤0.01% |
126,135
+4,341
| +4% | +$59.9K |
|
|
NVMI
3925
CALL
Nova
NVMI
$12.4B
| $1.81M | ﹤0.01% |
5,500
+2,700
| +96% | +$868K |
|
Similar funds
Millennium Management's Q4 2025 Portfolio in Review
As of Q4 2025, Millennium Management held 6,645 positions worth $238B, up 1.5% from $234B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Millennium Management's Q4 2025 filing shows 668 new, 2,203 increased, 2,701 reduced and 696 closed positions. Its largest new stake was iShares Russell 1000 ETF: 455,129 shares worth $170M. The largest sale was Microsoft, an estimated $572M.
By sector, the portfolio is most concentrated in Technology at 9.5% of assets, up from 9.3% a quarter earlier, followed by Healthcare and Financials.
- Millennium Management's largest Q4 2025 buy was iShares Russell 1000 ETF: 455,129 shares worth $170M.
- Millennium Management added most to iShares Core S&P 500 ETF in Q4 2025, an estimated $4.75B increase.
- Millennium Management's biggest Q4 2025 reduction was Microsoft, cutting an estimated $572M.
- Millennium Management fully exited Mr. Cooper in Q4 2025, selling an estimated $277M.
- Millennium Management's ten largest holdings make up 19% of its $238B portfolio in Q4 2025.
- Millennium Management opened 668 new positions and closed 696 in Q4 2025.
- Millennium Management's portfolio value rose 1.5% quarter-over-quarter to $238B.
Based on Millennium Management's 13F filing for Q4 2025, filed 17 Feb 2026.